—— |
(13R,14R)-4-benzyloxy-13,14-dihydroxy-2,11-dioxatricyclo[13.2.2.13,7]eicosa-1(18),3,5,7(20),1(19),16-hexaen-10-one |
172919-05-0 |
C25H24O6 |
420.462 |
—— |
combretastatin D-1 benzyl ether |
202645-49-6 |
C25H22O5 |
402.447 |
—— |
(2S,4R)-13-phenylmethoxy-3,6,15-trioxatetracyclo[14.2.2.110,14.02,4]henicosa-1(19),10(21),11,13,16(20),17-hexaen-7-one |
172919-12-9 |
C25H22O5 |
402.447 |
—— |
(3R,4S)-(-)-combretastatin D-1 |
117709-78-1 |
C18H16O5 |
312.322 |
—— |
(-)-(3S,4R)-combretastatin D-1 |
—— |
C18H16O5 |
312.322 |
—— |
combretastatin D-2 benzyl ether |
202645-48-5 |
C25H22O4 |
386.447 |
—— |
(13R,14R)-13,14-bis[[tert-butyl(dimethyl)silyl]oxy]-4-phenylmethoxy-2,11-dioxatricyclo[13.2.2.13,7]icosa-1(17),3,5,7(20),15,18-hexaen-10-one |
172919-11-8 |
C37H52O6Si2 |
648.987 |
—— |
3-[3-[4-[(1R,2R)-1,2-bis[[tert-butyl(dimethyl)silyl]oxy]-3-hydroxypropyl]phenoxy]-4-phenylmethoxyphenyl]propanoic acid |
202645-46-3 |
C37H54O7Si2 |
667.003 |
—— |
combretastatin D-2 |
126191-23-9 |
C18H16O4 |
296.323 |